NORTHERN TRUST CORP - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 39 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2021$826,000
-16.9%
371,944
-7.2%
0.00%
Q4 2020$994,000
+1.2%
400,857
+0.4%
0.00%
Q3 2020$982,000
-32.2%
399,152
-2.2%
0.00%
Q2 2020$1,449,000
+280.3%
407,932
+55.5%
0.00%
Q2 2019$381,000
-31.6%
262,351
-7.2%
0.00%
Q1 2019$557,000
+53.4%
282,782
+1.9%
0.00%
Q4 2018$363,000
-45.7%
277,557
+2.2%
0.00%
Q3 2018$668,000
-27.1%
271,531
-0.5%
0.00%
Q2 2018$916,000
-13.7%
272,825
+8.7%
0.00%
Q1 2018$1,062,000
+30.8%
250,997
+2.1%
0.00%
Q4 2017$812,000
-15.6%
245,820
-2.3%
0.00%
Q3 2017$962,000
+383.4%
251,610
+455.4%
0.00%
Q2 2017$199,00045,3010.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2019
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$82,0000.11%
Patriot Financial Group Insurance Agency, LLC 71,060$166,0000.08%
Willow Creek Wealth Management Inc. 24,224$57,0000.03%
WEBSTER BANK, N. A. 60,000$140,0000.02%
HighPoint Advisor Group LLC 34,000$98,0000.02%
Brown Advisory Securities, LLC 28,000$60,0000.02%
WMS Partners, LLC 18,000$42,0000.01%
WEDBUSH SECURITIES INC 33,900$79,0000.01%
ExodusPoint Capital Management, LP 56,618$132,0000.01%
Qube Research & Technologies Ltd 66,800$156,0000.01%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders